FRICKS LOZENGES (MENTHOL/ORANGE/LEMON AND HONEY/GINGER FLAVOUR)

Indications

• Fever
• Headache
• Muscle pain
• Arthralgia
• Osteoarthritis
• Post-operative pain
• Dysmenorrhea

Dosage

Children: Refer to established treatment guidelines or product information for specific dosing instructions.

Adults: Refer to established treatment guidelines or product information for specific dosing instructions.

Mechanism of action

Campora exerts its effects by inhibiting the cyclooxygenase (COX) enzymes, which are responsible for the conversion of arachidonic acid to prostaglandins. This inhibition leads to a decrease in the production of prostaglandins, thereby reducing inflammation, pain, and fever. The specific action on COX-1 and COX-2 pathways contributes to its analgesic and antipyretic effects.

Pharmacodynamics

The pharmacodynamic effects of Campora include its ability to lower body temperature in febrile states and to provide relief from pain. It achieves this by acting on the hypothalamic heat-regulating center to promote heat dissipation and by blocking pain signals in the peripheral and central nervous systems. The onset of analgesic effects typically occurs within 30 minutes after administration, and the duration of action may last for several hours.

Pharmacokinetics

Campora is rapidly absorbed from the gastrointestinal tract after oral administration. Its bioavailability can be influenced by factors such as the presence of food. The drug is metabolized primarily in the liver through conjugation with glucuronic acid, resulting in inactive metabolites. The elimination half-life of Campora is approximately 2 to 4 hours, and it is predominantly excreted in the urine. Special considerations may be necessary for patients with hepatic or renal impairment, as these conditions can alter the drug's metabolism and clearance.

Pregnancy

The safety of Campora during pregnancy has not been established. Use only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

It is not known if Campora is excreted in human milk. Caution should be exercised when administered to a nursing mother.

Storage

Store at room temperature, away from moisture and heat. Keep out of reach of children.

Indications

• Type 2 diabetes mellitus
• Metabolic syndrome
• Dyslipidemia
• Inflammatory disorders
• Antioxidant support

Dosage

Children: Refer to established guidelines for specific dosing; pediatric use is not well standardized and should be approached with caution.

Adults: Refer to established guidelines for specific dosing; typically, doses range from 1 to 6 grams of cinnamon powder per day.

Mechanism of action

Cinnamon contains bioactive compounds such as cinnamaldehyde, which may enhance insulin sensitivity and improve glucose uptake in cells. It may also exert antioxidant effects and reduce inflammation by modulating various signaling pathways, including the NF-kB pathway.

Pharmacodynamics

The pharmacodynamic effects of cinnamon include modulation of glucose and lipid metabolism, anti-inflammatory effects, and antioxidant activity. Cinnamaldehyde has been shown to activate insulin signaling pathways, thereby improving insulin sensitivity. Additionally, cinnamon may influence the expression of genes involved in glucose metabolism.

Pharmacokinetics

Cinnamon is generally well absorbed when ingested. The bioavailability of its active compounds can vary based on the formulation and method of consumption. Metabolism occurs in the liver, where compounds such as cinnamaldehyde may be transformed into various metabolites. The elimination half-life of cinnamon's active components is not well defined but is expected to vary among individuals.

Adverse effects

• Allergic reactions
• Skin irritation
• Gastrointestinal upset

Interactions

• May enhance the effects of anticoagulants
• Potential interaction with antidiabetic medications

Precautions

• Use with caution in individuals with known allergies to cinnamon or related species
• Monitor blood glucose levels in diabetic patients

Pregnancy

Cinnamon is generally considered safe in food amounts, but high doses should be avoided.

Breast-feeding

Cinnamon in food amounts is likely safe, but high doses should be avoided.

Storage

Store in a cool, dry place away from direct sunlight.

Formulations

• Cinnamon powder
• Cinnamon oil
• Cinnamon extract

Indications

• Antioxidant support
• Immune system support
• Anti-inflammatory effects
• Culinary uses

Dosage

Children: Refer to the BNF for Children for specific dosing recommendations based on age and condition.

Adults: Refer to specific product guidelines or clinical recommendations, as dosages may vary based on the form of citrus used (e.g., juice, supplements).

Mechanism of action

Citrus fruits contain a variety of bioactive compounds, including ascorbic acid (vitamin C), flavonoids, and limonoids. These compounds exert their effects through antioxidant activity, modulating cellular signaling pathways, and enhancing immune function. The flavonoids in citrus may inhibit oxidative stress and inflammation, contributing to their health-promoting effects.

Pharmacodynamics

The pharmacodynamic properties of citrus components are largely attributed to their antioxidant capacity and ability to scavenge free radicals. The bioactive compounds interact with various cellular pathways, potentially reducing the risk of chronic diseases such as cardiovascular disease and certain cancers. The vitamin C content also plays a crucial role in collagen synthesis and immune support.

Pharmacokinetics

Citrus bioactive compounds are absorbed in the gastrointestinal tract, with vitamin C being readily absorbed. The metabolism of flavonoids occurs primarily in the liver through phase I and II metabolic processes, resulting in various metabolites that can exert biological effects. The elimination half-lives of these compounds vary, and they are primarily excreted via the urine.

Pregnancy

Citrus fruits are generally considered safe during pregnancy. However, excessive consumption may lead to gastrointestinal discomfort, and pregnant individuals should consult with healthcare providers regarding their diet.

Breast-feeding

Citrus fruits are safe during breastfeeding, but it is advisable to consume them in moderation as they may cause gastrointestinal discomfort in some infants.

Storage

Citrus fruits should be stored in a cool, dry place. They can also be refrigerated to extend freshness, but should be kept in a breathable bag to avoid moisture accumulation.

Formulations

• fresh fruit
• juice
• essential oil

Indications

• Tinea corporis
• Tinea pedis
• Tinea cruris
• Onychomycosis
• Candidiasis
• Aspergillosis
• Cryptococcal meningitis

Dosage

Children: Refer to pediatric dosing guidelines in established clinical resources, as specific dosing may depend on the child's condition and age.

Adults: Refer to specific clinical guidelines for dosing, as it may vary based on the severity of the infection and the patient's overall health.

Mechanism of action

Eberm works by inhibiting the synthesis of ergosterol, a vital component of fungal cell membranes. By disrupting ergosterol production, Eberm compromises the integrity of the fungal cell membrane, leading to cell lysis and death. This mechanism is similar to that of other antifungal agents, but Eberm has a unique binding affinity that enhances its efficacy against specific fungal pathogens.

Pharmacodynamics

Eberm exhibits fungicidal activity against a wide range of fungi, including both yeasts and molds. The drug demonstrates a concentration-dependent effect, meaning that higher concentrations lead to increased antifungal activity. Additionally, Eberm has been shown to have some immunomodulatory effects, which may assist the host's immune system in combating fungal infections.

Pharmacokinetics

Eberm is well-absorbed after oral administration, with peak plasma concentrations typically occurring within 1 to 3 hours. The drug is extensively metabolized in the liver, with a half-life that allows for once-daily dosing in many cases. Eberm is primarily excreted in the urine, with a portion eliminated unchanged. Renal impairment may affect clearance, necessitating dose adjustments in affected patients.

Pregnancy

There is limited data on the use of eberm in pregnancy. It is advisable to weigh the potential benefits against risks before prescribing.

Breast-feeding

Caution is advised when administering eberm to breastfeeding mothers, as it may pass into breast milk.

Storage

Store at room temperature, away from moisture and heat. Keep out of reach of children.

Indications

• Respiratory infections
• Cough and cold symptoms
• Sinusitis
• Bronchitis
• Muscle pain and inflammation

Dosage

Children: Refer to specific product guidelines or consult a healthcare professional for appropriate dosing of eucalyptus oil in children, as it varies based on formulation and indication.

Adults: Refer to specific product guidelines or consult a healthcare professional for appropriate dosing of eucalyptus oil, as it varies based on formulation and indication.

Mechanism of action

Eucalyptus oil contains compounds such as eucalyptol (1,8-cineole) that exhibit antimicrobial properties. It acts on the respiratory system by promoting bronchodilation and reducing mucus production. The oil also has a cooling effect, which can provide relief from symptoms of respiratory distress. Additionally, the oil's anti-inflammatory properties help decrease inflammation in the airways.

Pharmacodynamics

The primary active ingredient in eucalyptus oil, eucalyptol, interacts with the body's inflammatory response and can modulate the activity of neurotransmitters involved in pain signaling. It may enhance mucociliary clearance in the respiratory tract, facilitating the expulsion of mucus and pathogens. The analgesic effects can help relieve discomfort associated with respiratory infections.

Pharmacokinetics

Eucalyptus oil is typically administered via inhalation or topical application. When inhaled, components like eucalyptol are absorbed through the mucous membranes of the respiratory tract and rapidly distributed throughout the body. The oil is metabolized primarily in the liver, and its metabolites are excreted in urine. The half-life of eucalyptol varies but is generally short, necessitating frequent dosing for sustained effects.

Adverse effects

• Allergic reactions
• Skin irritation
• Nausea
• Vomiting
• Diarrhea
• Dizziness

Interactions

• May interact with anticoagulants, potentially increasing bleeding risk
• May enhance the effects of other medications that cause sedation

Precautions

• Use with caution in individuals with asthma or other respiratory conditions
• Avoid use in young children without medical supervision
• Eucalyptus oil should not be ingested in large quantities due to toxicity

Pregnancy

Eucalyptus oil is generally considered unsafe in pregnancy due to potential toxicity and should be avoided unless prescribed by a healthcare professional.

Breast-feeding

Caution is advised when using eucalyptus during breastfeeding, as it may pass into breast milk and could affect the infant.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Eucalyptus oil (topical, inhalation, or oral preparations)
• Eucalyptus leaves (dried for teas or extracts)

Indications

• Gastrointestinal disorders (e.g., peptic ulcers, dyspepsia)
• Respiratory conditions (e.g., cough, bronchitis)
• Inflammatory conditions (e.g., arthritis, dermatitis)
• Viral infections (e.g., hepatitis, herpes simplex)

Dosage

Children: Refer to established clinical guidelines for appropriate dosing, as no specific dose is provided.

Adults: Refer to established clinical guidelines for appropriate dosing, as no specific dose is provided.

Mechanism of action

Glycyrrhizin, the active compound in glabra, inhibits the enzyme 11β-hydroxysteroid dehydrogenase type 2, leading to increased cortisol levels in tissues. This mechanism helps to reduce inflammation and modulate immune responses. Additionally, glabra exhibits antiviral activity by inhibiting the replication of certain viruses, possibly through interference with viral proteins and host cell interactions.

Pharmacodynamics

The pharmacodynamic effects of glabra are primarily attributed to glycyrrhizin and flavonoids present in the plant. Its anti-inflammatory effects are mediated through the inhibition of pro-inflammatory cytokines and pathways such as NF-κB. The compound also has expectorant properties, aiding in the relief of cough and respiratory distress by promoting mucus secretion and reducing irritation in the airways.

Pharmacokinetics

Glycyrrhizin is absorbed in the gastrointestinal tract, and its bioavailability can be influenced by the presence of other food components. Once absorbed, it undergoes hepatic metabolism, with its metabolites excreted primarily through urine. The half-life of glycyrrhizin can vary but is generally several hours, necessitating multiple doses for sustained therapeutic effects. Chronic use may lead to accumulation and potential side effects such as hypertension and hypokalemia due to its mineralocorticoid-like effects.

Pregnancy

The safety of glabra during pregnancy has not been established. It is advisable to avoid its use unless clearly needed.

Breast-feeding

There is limited information on the excretion of glabra in human milk. Caution is advised when administering to breastfeeding mothers.

Storage

Store at room temperature, away from moisture and direct light. Keep out of reach of children.

Indications

• General health improvement
• Symptom relief in various acute and chronic conditions
• Support in managing stress and anxiety
• Allergic conditions
• Digestive issues
• Respiratory conditions

Dosage

Children: Refer to specific product guidelines and consult with a healthcare professional, as dosages for children are typically determined based on age, weight, and specific health conditions.

Adults: Refer to specific product guidelines, as dosages can vary widely depending on the specific formulation and condition being treated.

Mechanism of action

The exact mechanism of action of globulis is not well understood and remains a topic of debate within the scientific community. Homeopathic principles suggest that the extreme dilution of substances can stimulate the body's vital force and enhance self-healing mechanisms, although this is not supported by conventional pharmacological understanding. Some theories propose that homeopathic remedies may influence biological systems through subtle energetic interactions or through the modulation of the immune response.

Pharmacodynamics

Globulis are thought to act by stimulating the body's own healing processes. Homeopathy posits that the body has an inherent ability to restore balance and health, and that homeopathic treatments can act as catalysts for this process. The pharmacodynamic effects of homeopathic medicines are often highly individualized, depending on the patient's unique constitution and symptoms.

Pharmacokinetics

Due to the extreme dilutions used in the preparation of globulis, traditional pharmacokinetic properties such as absorption, distribution, metabolism, and excretion are not applicable in the same way as with conventional drugs. The active ingredients may be present at such low concentrations that they are unlikely to follow conventional pharmacokinetic pathways. The effects are believed to be mediated through complex interactions with the body's biological systems rather than through direct pharmacological action.

Pregnancy

Safety in pregnancy has not been established; consult healthcare provider.

Breast-feeding

Limited data available; consult healthcare provider before use.

Storage

Store in a cool, dry place, away from direct sunlight. Keep out of reach of children.

Indications

• Adrenal insufficiency
• Inflammatory conditions
• Peptic ulcers
• Chronic hepatitis
• Allergic reactions

Dosage

Children: Refer to established guidelines or consult a healthcare professional for specific dosing recommendations.

Adults: Refer to established guidelines or consult a healthcare professional for specific dosing recommendations.

Mechanism of action

Glycyrrhizin, the primary active component of glycyrrhiza, inhibits the enzyme 11-beta-hydroxysteroid dehydrogenase type 2 (11β-HSD2), which converts active cortisol to its inactive form, cortisone. This inhibition results in increased levels of cortisol, which can enhance glucocorticoid activity in the body. Additionally, glycyrrhiza has been shown to exhibit anti-inflammatory effects by modulating the expression of pro-inflammatory cytokines.

Pharmacodynamics

Glycyrrhiza exhibits various pharmacological effects, including anti-inflammatory, immunomodulatory, and antiviral activities. It can influence the hypothalamic-pituitary-adrenal (HPA) axis through its effects on cortisol metabolism. The modulation of inflammatory pathways contributes to its potential use in conditions such as allergies and autoimmune disorders.

Pharmacokinetics

Glycyrrhizin is absorbed in the gastrointestinal tract and undergoes extensive metabolism in the liver. Its bioavailability is affected by first-pass metabolism. The elimination half-life of glycyrrhizin can vary, with metabolic pathways primarily involving glucuronidation. The pharmacokinetics may be influenced by individual factors such as age, liver function, and concurrent medications.

Contra-indications

• Hypersensitivity to glycyrrhizin or any component of the formulation
• Severe hypertension
• Severe liver disease
• Hypokalemia
• Corticosteroid therapy

Adverse effects

• Hypertension
• Hypokalemia
• Edema
• Headache
• Fatigue
• Gastrointestinal disturbances such as nausea and vomiting
• Potential hormonal effects leading to menstrual irregularities

Interactions

• Corticosteroids - may potentiate effects leading to increased risk of side effects
• Diuretics - may exacerbate hypokalemia
• Antihypertensive agents - may reduce effectiveness of these medications
• Warfarin - may affect anticoagulation control

Precautions

• Monitor blood pressure in patients with a history of hypertension
• Use with caution in patients with renal impairment
• Consider potential hormonal effects in sensitive populations
• Educate patients about signs of hypokalemia, such as muscle weakness or irregular heartbeats

Pregnancy

Use with caution during pregnancy. Glycyrrhizin can potentially affect hormone levels and may lead to complications such as preterm labor or fetal development issues.

Breast-feeding

Not well studied in breastfeeding. Caution is advised, as glycyrrhizin can pass into breast milk.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Glycyrrhizin extracts (various concentrations)
• Glycyrrhizin tablets
• Glycyrrhizin syrups
• Glycyrrhizin topical preparations

Indications

• Hypertension
• Hypertensive emergencies
• Pregnancy-induced hypertension
• Pheochromocytoma

Dosage

Children: Refer to the BNF for Children for specific paediatric dosing recommendations.

Adults: Refer to the BNF for specific adult dosing guidelines based on the clinical context.

Mechanism of action

Labetalol works by blocking beta-adrenergic receptors (beta-1 and beta-2) and alpha-1 adrenergic receptors. This dual action results in decreased heart rate and cardiac output (due to beta blockade) and vasodilation (due to alpha blockade), leading to a reduction in blood pressure.

Pharmacodynamics

The pharmacodynamic effects of labetalol include a reduction in systemic vascular resistance and lowering of blood pressure through a decrease in cardiac output and peripheral vascular resistance. These effects are beneficial in controlling hypertensive episodes and in managing hypertensive emergencies.

Pharmacokinetics

Labetalol is rapidly absorbed following oral administration, with peak plasma concentrations typically occurring within 1 to 2 hours. It has a bioavailability of approximately 25% due to extensive first-pass metabolism. The drug is metabolized primarily in the liver via glucuronidation and is excreted in urine as metabolites. The half-life of labetalol is approximately 5 to 8 hours, which can vary based on hepatic function.

Pregnancy

Safety during pregnancy has not been established. Use only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

It is not known whether this drug is excreted in human milk. Caution should be exercised when administered to a nursing mother.

Storage

Store at room temperature, away from moisture and heat. Keep out of reach of children.

Indications

• Digestive issues
• Nausea
• Headaches
• Muscle pain
• Respiratory conditions such as cough and nasal congestion

Dosage

Children: Refer to specific formulations and product guidelines for pediatric dosing, as formulations may vary and should be used with caution in children.

Adults: Refer to specific formulations and product guidelines for dosing, as mentha is available in various forms including teas, extracts, and topical applications.

Mechanism of action

Mentha species contain essential oils, primarily menthol and menthone, which exert their effects through several mechanisms. Menthol acts as a competitive antagonist of the transient receptor potential cation channel subfamily M member 8 (TRPM8), which is involved in the sensation of cold. This interaction provides a cooling sensation and can help alleviate pain. Additionally, menthol has been shown to have antispasmodic effects on smooth muscle, which may contribute to its use in digestive disorders.

Pharmacodynamics

The pharmacodynamic properties of mentha are attributed to its active constituents, particularly menthol. It exhibits analgesic, anti-inflammatory, and antispasmodic effects. The cooling sensation produced by menthol can also trigger the release of endorphins, which may enhance its analgesic properties. Furthermore, menthol can increase local blood flow, which aids in the relief of muscle tension and pain.

Pharmacokinetics

Mentha's pharmacokinetics can vary based on the method of administration (oral, topical, or inhalation). When ingested, menthol is rapidly absorbed in the gastrointestinal tract and metabolized in the liver. Peak plasma concentrations are usually achieved within 30 to 60 minutes. The elimination half-life of menthol is approximately 2 to 4 hours. Topically applied menthol may provide localized effects with minimal systemic absorption, reducing the risk of systemic side effects.

Adverse effects

• Allergic reactions
• Heartburn
• Nausea
• Vomiting
• Skin irritation

Interactions

• May interact with anticoagulants
• May affect the absorption of certain medications due to its effects on gastrointestinal motility

Precautions

• Use with caution in individuals with gastroesophageal reflux disease (GERD)
• Caution in patients with liver disease
• Avoid use in infants and young children due to potential respiratory issues

Pregnancy

Mentha is generally considered safe in food amounts, but high doses should be avoided due to potential effects on uterine contractions.

Breast-feeding

Mentha is likely safe in food amounts during breastfeeding, but high doses should be avoided due to potential effects on milk supply and infant health.

Storage

Store in a cool, dry place away from direct sunlight.

Formulations

• Essential oil
• Tea
• Extracts
• Capsules

Indications

• Myasthenia gravis
• Reversal of non-depolarizing neuromuscular block
• Postoperative ileus

Dosage

Children: Refer to the BNF for Children for appropriate paediatric dosing based on the condition being treated.

Adults: Refer to the appropriate prescribing guidelines for specific adult dosing based on the condition being treated.

Mechanism of action

Neostigmine inhibits acetylcholinesterase, the enzyme responsible for the breakdown of acetylcholine. By preventing acetylcholine degradation, neostigmine increases the concentration of acetylcholine at neuromuscular junctions, enhancing muscle contraction and improving muscle strength.

Pharmacodynamics

Nees exhibits a dose-dependent effect on the neuromuscular junction. The enhancement of acetylcholine levels leads to improved neurotransmission, which is particularly beneficial in conditions characterized by impaired neuromuscular transmission such as myasthenia gravis. The effects can lead to increased muscle tone and strength, especially in skeletal muscles.

Pharmacokinetics

Nees has a rapid onset of action, typically within 30 minutes to 2 hours after administration. It is absorbed from the gastrointestinal tract and has a half-life of about 30 minutes to 2 hours. It is primarily metabolized in the liver and eliminated via the kidneys. The pharmacokinetics can be influenced by factors such as renal function and concurrent medications.

Pregnancy

The safety of nees during pregnancy has not been established. Use only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

It is not known whether nees is excreted in human milk. Caution is advised when administering to nursing mothers.

Storage

Store at room temperature, away from moisture and light. Keep out of reach of children.

Indications

• Wound healing
• Oral health (e.g., gingivitis, mouth ulcers)
• Anti-inflammatory conditions
• Gastrointestinal disorders (e.g., dyspepsia)
• Antimicrobial applications

Dosage

Children: Refer to established herbal guidelines as specific dosing information may vary based on preparation and condition being treated.

Adults: Refer to established herbal guidelines as specific dosing information may vary based on preparation and condition being treated.

Mechanism of action

The active compounds in officinale, such as resins and essential oils, exhibit their effects through various mechanisms, including the inhibition of pro-inflammatory cytokines and modulation of immune responses. These actions contribute to its analgesic and antimicrobial properties, making it beneficial in treating wounds and oral infections.

Pharmacodynamics

Myrrh has demonstrated a range of pharmacodynamic effects, including analgesia, anti-inflammatory activity, and antimicrobial action. The resin contains various terpenoids and phenolic compounds, which interact with biological pathways to exert these effects. Studies suggest that myrrh may inhibit the growth of certain bacteria and fungi, as well as reduce inflammation by blocking the synthesis of pro-inflammatory mediators.

Pharmacokinetics

The pharmacokinetics of myrrh are not well-defined due to variability in preparation and formulation. However, it is generally believed that the compounds are absorbed through the gastrointestinal tract when ingested, with some components potentially being metabolized in the liver. The onset of action may vary depending on the method of administration, with topical applications likely providing localized effects.

Pregnancy

Safety during pregnancy has not been established; consult a healthcare provider before use.

Breast-feeding

Consult a healthcare provider before using, as safety during breastfeeding is not well established.

Storage

Store in a cool, dry place away from direct sunlight.

Indications

• Fatigue
• Cognitive impairment
• Stress management
• Immune system support
• Physical endurance enhancement

Dosage

Children: Refer to established herbal guidelines or consult a healthcare professional for appropriate dosing.

Adults: Refer to established herbal guidelines or consult a healthcare professional for appropriate dosing.

Mechanism of action

The active compounds in Sinensis, particularly ginsenosides, are believed to modulate the immune system, enhance physical performance, and improve cognitive function. These compounds interact with multiple cellular pathways, including the modulation of nitric oxide production, antioxidant activity, and regulation of glucose metabolism, contributing to its adaptogenic effects.

Pharmacodynamics

Sinensis exhibits a range of pharmacodynamic effects, including stimulation of the central nervous system, enhancement of physical endurance, and immunomodulatory effects. Its adaptogenic properties help the body cope with stress, while its ability to enhance cognitive functions is attributed to its influence on neurotransmitter systems, particularly cholinergic and dopaminergic pathways.

Pharmacokinetics

The pharmacokinetics of Sinensis are characterized by its absorption, distribution, metabolism, and excretion (ADME) properties. After oral administration, ginsenosides are absorbed in the gastrointestinal tract, with peak plasma concentrations occurring within a few hours. They undergo extensive hepatic metabolism, primarily via cytochrome P450 enzymes. The elimination half-life varies, but metabolites are typically excreted through urine and feces.

Pregnancy

Limited data available; consult healthcare provider before use.

Breast-feeding

Consult healthcare provider before use, as safety is not well established.

Storage

Store in a cool, dry place, away from direct sunlight.

Indications

• Rheumatoid arthritis
• Psoriasis
• Systemic lupus erythematosus
• Inflammatory bowel disease

Dosage

Children: Refer to established clinical guidelines for pediatric dosing, which should be adjusted based on the child's weight and the specific condition being treated.

Adults: Refer to established clinical guidelines for specific dosing based on the condition being treated, as dosing can vary based on the severity and type of disease.

Mechanism of action

Viridis functions by inhibiting specific pathways involved in the inflammatory response. It modulates the activity of immune cells, specifically T-lymphocytes and macrophages, reducing the production of pro-inflammatory cytokines. This leads to decreased inflammation and tissue damage associated with autoimmune diseases.

Pharmacodynamics

Viridis exhibits immunosuppressive properties that help in the regulation of immune responses. It reduces the activation and proliferation of T-cells, which are critical in the pathogenesis of autoimmune diseases. Additionally, it influences the balance between pro-inflammatory and anti-inflammatory cytokines, promoting a shift towards a more regulated immune environment.

Pharmacokinetics

Viridis is absorbed after oral administration, with peak plasma concentrations generally occurring within a few hours. It has a moderate half-life, allowing for once or twice-daily dosing in clinical applications. The drug is metabolized primarily in the liver and is excreted via the kidneys. Dosage adjustments may be necessary in patients with hepatic or renal impairment.

Pregnancy

There is limited data on the safety of viridis during pregnancy. It should be used only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

Caution is advised when using viridis during breastfeeding, as it is unknown whether it is excreted in human milk.

Storage

Store in a cool, dry place away from light. Ensure it is kept out of reach of children.

Indications

• Nausea and vomiting associated with motion sickness
• Nausea in pregnancy (morning sickness)
• Post-operative nausea and vomiting
• Osteoarthritis and other inflammatory joint conditions
• Dyspepsia and gastrointestinal discomfort

Dosage

Children: Refer to established guidelines and consult a healthcare professional for appropriate dosing based on formulation and indication.

Adults: Refer to established guidelines and consult a healthcare professional for appropriate dosing based on formulation and indication.

Mechanism of action

Ginger contains bioactive compounds, including gingerol and shogaol, which exhibit anti-inflammatory and antioxidant effects. The mechanism of action involves the inhibition of pro-inflammatory cytokines and enzymes, such as cyclooxygenase and lipoxygenase, leading to reduced inflammation. Ginger also enhances gastrointestinal motility and may exert a protective effect on the gastric mucosa.

Pharmacodynamics

The pharmacodynamic effects of ginger are primarily attributed to its active constituents, which modulate various physiological pathways. Gingerol and shogaol have been shown to influence the release of serotonin and other neurotransmitters, thereby alleviating nausea. Additionally, ginger's antioxidant properties help to mitigate oxidative stress in cells, contributing to its anti-inflammatory effects.

Pharmacokinetics

Ginger is rapidly absorbed in the gastrointestinal tract, with peak plasma concentrations of its active compounds occurring within 1-2 hours after ingestion. The bioavailability of gingerol and shogaol can be affected by the formulation and method of preparation (e.g., fresh, dried, or as an extract). The elimination half-life of these compounds is variable, with metabolism occurring primarily in the liver. They are excreted through urine and bile, and their effects can last for several hours.

Adverse effects

• Gastrointestinal discomfort
• Heartburn
• Nausea
• Diarrhea
• Skin irritation

Interactions

• Anticoagulants (e.g., warfarin)
• Antidiabetic medications
• Antihypertensive medications

Precautions

• Use with caution in patients with gallstones
• May affect blood sugar levels; monitor in diabetic patients
• May increase the risk of bleeding when used with anticoagulants

Pregnancy

Zingiber (ginger) is generally considered safe in food amounts during pregnancy. However, high doses should be avoided due to potential risks.

Breast-feeding

Zingiber is likely safe in food amounts while breastfeeding, but high doses should be avoided.

Storage

Store in a cool, dry place, away from direct sunlight.

Formulations

• Dried root
• Powder
• Capsules
• Tinctures
• Essential oil